ARQT News and Press, Arcutis Biotherapeutics Inc. From 07/28/23

2023-07-28 05:31:08 ET Summary Arcutis has launched Zoryve, a topical cream for the treatment of psoriasis, and is focused on transitioning to a commercial-stage company. The company has made progress with major pharmacy benefit managers and positioned Zoryve to be highly accessib...

WESTLAKE VILLAGE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will host a conference call and webcast...

Coverage at CVS Caremark, the largest pharmacy benefit manager (PBM) in the United States was effective July 5 All three of the largest pharmacy benefit managers in the United States have now included ZORYVE on formulary, providing access to 80% of commercial lives ZORYVE is a once-daily,...

2023-07-12 17:31:16 ET Gainers: Evolus ( NASDAQ: EOLS ) +5% . Omega Therapeutics ( OMGA ) +5% . Kodiak Sciences ( KOD ) +4% . Amazon ( AMZN ) +4% . Cara Therapeutics ( CARA ) +3% . Losers: ViaSat ( VSAT ) -7% ...

2023-07-12 12:49:58 ET Summary Arcutis Biotherapeutics' FDA-approved product, Zoryve, targets plaque psoriasis and is being developed for other dermatological diseases. The company's Q1 2023 revenues were $2.8 million, with a net loss of $80.1 million. The company faces intense co...

2023-06-28 17:34:03 ET Gainers: American Outdoor Brands ( AOUT ) +9% . Overstock ( OSTK ) +5% . Purple Innovation ( PRPL ) +5% . Farmer Brothers  ( FARM ) +5% . Arcutis Biotherapeutics ( ARQT ) +4% . Losers: CorMedix...

2023-06-15 17:38:38 ET Gainers: Adobe  ( ADBE ) +5% . Arcturus Therapeutics  ( ARCT ) +5% . Xeris Biopharma Holdings ( XERS ) +4% . Castle Biosciences ( CSTL ) +4% . Enovix Corporation ( ENVX ) +4% . Losers: Mil...

2023-06-09 17:33:00 ET Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence . The medical dermatology company's stock closed last week at $8.20 and rose to as h...

Senior Vice President and Chief Commercial Officer (CCO) Ken Lock Stepping Down Ayisha Jeter Appointed Interim CCO WESTLAKE VILLAGE, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focus...

2023-05-13 19:53:08 ET Arcutis Biotherapeutics, Inc. (ARQT) Q1 2023 Results Conference Call May 09, 2023 04:30 PM ET Company Participants Eric McIntyre - Head of Investor Relations Frank Watanabe - President & Chief Executive Officer Patrick Burnett - Chief M...